What is this study trying to find out about bone disorders?

This study aims to understand the biological mechanisms involved in bone, calcium, and growth plate diseases and identify factors that predict how these conditions progress. Sponsored by University Hospital, Toulouse, it seeks to better understand these diseases to support future research. Participants contribute by providing biological samples and clinical data over time.

Who may be eligible for this bone disorder clinical trial?

Anyone from birth up to 99 years old with a growth plate or bone pathology may be eligible, as long as they can understand French and give consent. Pregnant or breastfeeding women and those under legal protection cannot participate. Please review eligibility criteria for more details.

Is there any cost to participate in this bone disorder clinical trial?

Study-related care, including all tests and study procedures, is provided at no cost. However, personal travel and other expenses may vary and are not guaranteed to be covered. Participants should plan accordingly for any costs related to attending study visits.

Actively Recruiting

Age: 0 - 99Years

All Genders

ID06444503

Creating a Biological Collection to Study and Predict Progression in Bone, Calcium, and Growth Plate Disorders

Led by University Hospital, Toulouse · Updated on 2026-06-05

350

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are collecting biological and clinical data from patients with progressive bone, calcium, and growth plate diseases. The goal is to better understand the biological processes behind these conditions and to identify factors that predict disease progression and potential new treatment targets. This observational study is sponsored by University Hospital, Toulouse, and focuses on patients of all ages up to 99 years old with these pathologies. Participants will undergo regular clinical monitoring, including blood and urine tests. In cases where surgery is part of the treatment, surgical residues may also be collected and preserved. These biological samples and clinical data will be gathered over an average period of 5 years to build a comprehensive collection for ongoing research. Throughout the study, patients will have clinical and biological evaluations to provide data for research. The main measure is the building of this biological and clinical collection from day 0 through study completion. Researchers will also look for markers that may indicate disease progression based on new insights gained from the data. Participants will be monitored regularly as part of their routine care, and the study may last up to 5 years or more.

CONDITIONS

Brief Title

Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

Who Can Participate

Age: 0 - 99Years

All Genders

Eligibility Criteria

You may qualify if you...

Children (from birth) with growth plate or bone pathology
Patients affiliated to or benefiting from a social security scheme
Patients able to receive information about the study and to understand the information form in order to participate in the study, including mastery of the French language
Not being subject to a restriction of rights by the judicial authorities
Patients or legal representatives having given their consent to participate in the study (expression of non-opposition)

You will not qualify if you...

Patients under legal protection (guardianship, curatorship or safeguard of justice)
Pregnant or breast-feeding women

Research Team

Thomas EDOUARD, MD

Sanaa EDDIRY

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here